Copyright Reports & Markets. All rights reserved.

Global Allergy Immunotherapy Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Allergy Immunotherapy Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Subcutaneous Immunotherapy
    • 1.3.3 Sublingual Immunotherapy
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Allergy Immunotherapy Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Allergic Rhinitis
    • 1.4.3 Allergic Asthma
    • 1.4.4 Others
  • 1.5 Global Allergy Immunotherapy Market Size & Forecast
    • 1.5.1 Global Allergy Immunotherapy Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Allergy Immunotherapy Sales Quantity (2021-2032)
    • 1.5.3 Global Allergy Immunotherapy Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 ALK-Abello
    • 2.1.1 ALK-Abello Details
    • 2.1.2 ALK-Abello Major Business
    • 2.1.3 ALK-Abello Allergy Immunotherapy Product and Services
    • 2.1.4 ALK-Abello Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ALK-Abello Recent Developments/Updates
  • 2.2 Stallergenes Greer
    • 2.2.1 Stallergenes Greer Details
    • 2.2.2 Stallergenes Greer Major Business
    • 2.2.3 Stallergenes Greer Allergy Immunotherapy Product and Services
    • 2.2.4 Stallergenes Greer Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Stallergenes Greer Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Allergy Immunotherapy Product and Services
    • 2.3.4 Merck Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Allergy Therapeutics
    • 2.4.1 Allergy Therapeutics Details
    • 2.4.2 Allergy Therapeutics Major Business
    • 2.4.3 Allergy Therapeutics Allergy Immunotherapy Product and Services
    • 2.4.4 Allergy Therapeutics Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Allergy Therapeutics Recent Developments/Updates
  • 2.5 HAL
    • 2.5.1 HAL Details
    • 2.5.2 HAL Major Business
    • 2.5.3 HAL Allergy Immunotherapy Product and Services
    • 2.5.4 HAL Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 HAL Recent Developments/Updates
  • 2.6 Holister Stier
    • 2.6.1 Holister Stier Details
    • 2.6.2 Holister Stier Major Business
    • 2.6.3 Holister Stier Allergy Immunotherapy Product and Services
    • 2.6.4 Holister Stier Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Holister Stier Recent Developments/Updates
  • 2.7 Leti
    • 2.7.1 Leti Details
    • 2.7.2 Leti Major Business
    • 2.7.3 Leti Allergy Immunotherapy Product and Services
    • 2.7.4 Leti Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Leti Recent Developments/Updates
  • 2.8 WOLW Pharma
    • 2.8.1 WOLW Pharma Details
    • 2.8.2 WOLW Pharma Major Business
    • 2.8.3 WOLW Pharma Allergy Immunotherapy Product and Services
    • 2.8.4 WOLW Pharma Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 WOLW Pharma Recent Developments/Updates

3 Competitive Environment: Allergy Immunotherapy by Manufacturer

  • 3.1 Global Allergy Immunotherapy Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Allergy Immunotherapy Revenue by Manufacturer (2021-2026)
  • 3.3 Global Allergy Immunotherapy Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Allergy Immunotherapy by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Allergy Immunotherapy Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Allergy Immunotherapy Manufacturer Market Share in 2025
  • 3.5 Allergy Immunotherapy Market: Overall Company Footprint Analysis
    • 3.5.1 Allergy Immunotherapy Market: Region Footprint
    • 3.5.2 Allergy Immunotherapy Market: Company Product Type Footprint
    • 3.5.3 Allergy Immunotherapy Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Allergy Immunotherapy Market Size by Region
    • 4.1.1 Global Allergy Immunotherapy Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Allergy Immunotherapy Consumption Value by Region (2021-2032)
    • 4.1.3 Global Allergy Immunotherapy Average Price by Region (2021-2032)
  • 4.2 North America Allergy Immunotherapy Consumption Value (2021-2032)
  • 4.3 Europe Allergy Immunotherapy Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Allergy Immunotherapy Consumption Value (2021-2032)
  • 4.5 South America Allergy Immunotherapy Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Allergy Immunotherapy Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 5.2 Global Allergy Immunotherapy Consumption Value by Type (2021-2032)
  • 5.3 Global Allergy Immunotherapy Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 6.2 Global Allergy Immunotherapy Consumption Value by Application (2021-2032)
  • 6.3 Global Allergy Immunotherapy Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 7.2 North America Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 7.3 North America Allergy Immunotherapy Market Size by Country
    • 7.3.1 North America Allergy Immunotherapy Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Allergy Immunotherapy Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 8.2 Europe Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 8.3 Europe Allergy Immunotherapy Market Size by Country
    • 8.3.1 Europe Allergy Immunotherapy Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Allergy Immunotherapy Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Allergy Immunotherapy Market Size by Region
    • 9.3.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 10.2 South America Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 10.3 South America Allergy Immunotherapy Market Size by Country
    • 10.3.1 South America Allergy Immunotherapy Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Allergy Immunotherapy Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Allergy Immunotherapy Market Size by Country
    • 11.3.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Allergy Immunotherapy Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Allergy Immunotherapy Market Drivers
  • 12.2 Allergy Immunotherapy Market Restraints
  • 12.3 Allergy Immunotherapy Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Allergy Immunotherapy and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Allergy Immunotherapy
  • 13.3 Allergy Immunotherapy Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Allergy Immunotherapy Typical Distributors
  • 14.3 Allergy Immunotherapy Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Allergy Immunotherapy market size was valued at US$ 1921 million in 2025 and is forecast to a readjusted size of US$ 3040 million by 2032 with a CAGR of 6.9% during review period.
    Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response. The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
    The global allergy immunotherapy market is primarily driven by the rising prevalence of allergic conditions, such as allergic rhinitis, asthma, and food allergies, which affect hundreds of millions of individuals worldwide. Growing awareness about long-term treatment options and the effectiveness of immunotherapy in providing sustained symptom relief is increasing its adoption. Additionally, advancements in diagnostic techniques, improved formulations such as sublingual tablets, and support from regulatory authorities have facilitated market growth. The increasing demand for personalized medicine and a shift toward disease-modifying therapies are further propelling the market forward.
    Despite its therapeutic potential, the allergy immunotherapy market faces several challenges. The long treatment duration—often lasting three to five years—can lead to poor patient compliance and high dropout rates. High upfront costs and limited reimbursement in some regions restrict accessibility for many patients. Moreover, the requirement for specialized healthcare infrastructure and trained professionals, especially for subcutaneous immunotherapy, limits adoption in low-resource settings. Safety concerns, including the risk of systemic allergic reactions, also hinder broader acceptance, particularly among pediatric and elderly populations. These barriers collectively slow market penetration and limit the therapy’s full potential.
    This report is a detailed and comprehensive analysis for global Allergy Immunotherapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Allergy Immunotherapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Allergy Immunotherapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Allergy Immunotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Allergy Immunotherapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Allergy Immunotherapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Allergy Immunotherapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, WOLW Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Allergy Immunotherapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Subcutaneous Immunotherapy
    Sublingual Immunotherapy
    Market segment by Application
    Allergic Rhinitis
    Allergic Asthma
    Others
    Major players covered
    ALK-Abello
    Stallergenes Greer
    Merck
    Allergy Therapeutics
    HAL
    Holister Stier
    Leti
    WOLW Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Allergy Immunotherapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Allergy Immunotherapy, with price, sales quantity, revenue, and global market share of Allergy Immunotherapy from 2021 to 2026.
    Chapter 3, the Allergy Immunotherapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Allergy Immunotherapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Allergy Immunotherapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Allergy Immunotherapy.
    Chapter 14 and 15, to describe Allergy Immunotherapy sales channel, distributors, customers, research findings and conclusion.

    Buy now